Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug

Barra, 2000, Modified drug release from inert matrix tablets prepared from formulation of identical composition but different organizations, J. Control. Release, 65, 419, 10.1016/S0168-3659(99)00220-5 Cao, 2004, Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions, Int. J. Pharm., 274, 107, 10.1016/j.ijpharm.2004.01.020 Chauhan, 2005, Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique, Eur. J. Pharm. Sci., 26, 219, 10.1016/j.ejps.2005.06.005 Chopra, 2007, Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experiment design, Eur. J. Pharm. Biopharm., 66, 73, 10.1016/j.ejpb.2006.09.001 Fujii, 2005, Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone, Int. J. Pharm., 293, 145, 10.1016/j.ijpharm.2004.12.018 Gupta, 2001, Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent, Pharm. Dev. Technol., 6, 563, 10.1081/PDT-120000294 Hirasawa, 2003, Physicochemical characterization and drug release studies of nilvadipine solid dispersion using water-insoluble polymer as a carrier, Drug Dev. Ind. Pharm., 29, 339, 10.1081/DDC-120018207 Horisawa, 2000, Physical properties of solid dispersion of a nonsteroidal anti-inflammatory drug (M-5011) with Eudragit E, Drug Dev. Ind. Pharm., 26, 1271, 10.1081/DDC-100102308 Karavas, 2007, Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix, Int. J. Pharm., 340, 76, 10.1016/j.ijpharm.2007.03.037 Leonardi, 2007, Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters, AAPS PharmSciTech., 8, E1, 10.1208/pt0804108 Maggi, 2000, High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms, Int. J. Pharm., 195, 229, 10.1016/S0378-5173(99)00402-0 Maggi, 2002, Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimension study, Biomaterials, 23, 1113, 10.1016/S0142-9612(01)00223-X Rao, 2003, Design of pH-independent controlled release matrix tablets for acidic drugs, Int. J. Pharm., 252, 81, 10.1016/S0378-5173(02)00622-1 Sahoo, 2009, Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidone® SR, AAPS PharmSciTech., 10, 27, 10.1208/s12249-008-9175-0 Seburg, 2006, Photosensitized degradation of losartan potassium in an extemporaneous suspension formulation, J. Pharm. Biomed. Anal., 42, 411, 10.1016/j.jpba.2006.04.030 Takeuchi, 2004, Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method, Powder Technol., 141, 187, 10.1016/j.powtec.2004.03.007 Tanaka, 2005, Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine, J. Control. Release, 108, 386, 10.1016/j.jconrel.2005.08.024 Tran, 2008, Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release, J. Control. Release, 129, 59, 10.1016/j.jconrel.2008.04.001 Tran, 2009, Dissolution-modulating mechanism of alkalizers and polymers in nanoemulsifying solid dispersion containing acidic drug, Eur. J. Pharm. Biopharm., 72, 83, 10.1016/j.ejpb.2008.12.009 Tran, 2010, Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility, Expert Opin. Drug Deliv., 7, 647, 10.1517/17425241003645910 Tran, 2010, Physicochemical principles of controlled release solid dispersion containing a poorly water-soluble drug, Ther. Deliv., 1, 51, 10.4155/tde.10.3 Yi, 2008, Formulation of a extended release tablet containing dexibuprofen, Arch. Pharm. Res., 31, 1637, 10.1007/s12272-001-2162-6 Yi, 2008, Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose, Eur. J. Pharm. Sci., 34, 274, 10.1016/j.ejps.2008.04.010